Hamilton, Canada
Synapse Life Science Consortium, founded in 2017, serves as the strategic broker for the Hamilton ecosystem, aiding the commercialization of health innovations. As a neutral advocate and strategic concierge, the consortium strengthens partnerships among key public and private-sector stakeholders, positioning themselves at the forefront of Biotechnology and Health Care industries.
Based in Canada, Synapse is closely allied with Canada's most research-intensive university and Ontario's comprehensive hospital network, fostering collaborations that leverage more than $500m in annual research investments. Their network encompasses over 25,000 life science professionals, forming a dynamic health cluster for entrepreneurs and innovators.
The most recent financial milestone was a $300.00K Seed Round on 20 April 2022, led by the McMaster Seed Fund (MSF). This investment reinforces Synapse's commitment to advancing health innovation commercialization through strategic alliances within the ecosystem.
